Literature DB >> 9667560

Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.

K H Rand1, H Houck, N D Denslow, K M Heilman.   

Abstract

OBJECTIVES: Oligoclonal bands are a characteristic finding in the CSF of patients with multiple sclerosis, yet their target antigen(s) remain unknown. The objective was to determine whether a filamentous phage peptide library could be employed to allow the oligoclonal bands to select their own target epitopes.
METHODS: CSF IgG antibody from 14 patients with multiple sclerosis and 14 controls was used to select individual phage clones from a bacteriophage library containing approximately 4 x 10(7) different hexamers expressed on its surface pIII protein. The amino acid sequence selected was deduced by sequencing the DNA of the genetically engineered insert.
RESULTS: In general, after three rounds of selection, CSF from both patients with multiple sclerosis and controls selected one to two consistent peptide motifs. Five out of 14 patients with multiple sclerosis, and one control, selected the amino acid sequence motif, RRPFF. Given 20 possible amino acids per position, the likelihood of five patients selecting the same linear five amino acid sequence is at most 1.6 x 10(-3), corrected for the number of clones sequenced. A GenBank computer search showed that this sequence is found in the Epstein-Barr Virus nuclear antigen (EBNA-1), and a heat shock protein alphaB crystallin. Human serum antibodies to a synthetic peptide containing RRPFF were virtually exclusively found in patients with prior infection by Epstein-Barr virus. Other studies have suggested a relation between Epstein-Barr virus infection and multiple sclerosis, including nearly 100% Epstein-Barr virus seropositivity among patients with multiple sclerosis and increased concentrations of antibody to EBNA in CSF of patients with multiple sclerosis. By antigen specific immunoblotting, antibodies to the RRPFF motif in the CSF were shown to correspond to a subset of oligoclonal bands in the CSF from the same patient.
CONCLUSION: This study shows that phage epitope display libraries may be used to select amino acid motifs which are potentially relevant to the pathogenesis of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667560      PMCID: PMC2170146          DOI: 10.1136/jnnp.65.1.48

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

1.  The use of synthetic peptide combinatorial libraries for the identification of bioactive peptides.

Authors:  R A Houghten; J R Appel; S E Blondelle; J H Cuervo; C T Dooley; C Pinilla
Journal:  Biotechniques       Date:  1992-09       Impact factor: 1.993

2.  Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.

Authors:  F Felici; L Castagnoli; A Musacchio; R Jappelli; G Cesareni
Journal:  J Mol Biol       Date:  1991-11-20       Impact factor: 5.469

3.  Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors.

Authors:  H M Cheng; Y T Foong; C K Sam; U Prasad; J Dillner
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Immunological differentiation between neuroborreliosis and multiple sclerosis.

Authors:  J Heller; G Holzer; K Schimrigk
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

5.  Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens.

Authors:  J Greenwood; A E Willis; R N Perham
Journal:  J Mol Biol       Date:  1991-08-20       Impact factor: 5.469

6.  Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update.

Authors:  G Keir; R W Luxton; E J Thompson
Journal:  Ann Clin Biochem       Date:  1990-09       Impact factor: 2.057

7.  Design, construction and function of a multicopy display vector using fusions to the major coat protein of bacteriophage M13.

Authors:  W Markland; B L Roberts; M J Saxena; S K Guterman; R C Ladner
Journal:  Gene       Date:  1991-12-20       Impact factor: 3.688

8.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10

9.  Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein.

Authors:  P F Bray; J Luka; P F Bray; K W Culp; J P Schlight
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

10.  Isolation of sequences from a random-sequence expression library that mimic viral epitopes.

Authors:  J A Lenstra; J H Erkens; J G Langeveld; W P Posthumus; R H Meloen; F Gebauer; I Correa; L Enjuanes; K K Stanley
Journal:  J Immunol Methods       Date:  1992-08-10       Impact factor: 2.303

View more
  10 in total

Review 1.  Development of anti-CD20 therapy for multiple sclerosis.

Authors:  Beatrix Bartok; Gregg J Silverman
Journal:  Exp Cell Res       Date:  2011-04-12       Impact factor: 3.905

Review 2.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

3.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Cerebrospinal fluid in multiple sclerosis.

Authors:  Kottil W Rammohan
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

6.  Epitope analysis of cerebrospinal fluid IgG in Japanese multiple sclerosis patients using phage display method.

Authors:  Juichi Fujimori; Ichiro Nakashima; Kazuo Fujihara; Tatsuro Misu; Shigeru Sato; Yasuto Itoyama
Journal:  Mult Scler Int       Date:  2011-11-10

7.  B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.

Authors:  Heather L Wilson
Journal:  Biologics       Date:  2012-05-07

8.  PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.

Authors:  H Benjamin Larman; Uri Laserson; Luis Querol; Katrijn Verhaeghen; Nicole L Solimini; George Jing Xu; Paul L Klarenbeek; George M Church; David A Hafler; Robert M Plenge; Peter A Nigrovic; Philip L De Jager; Ilse Weets; Geert A Martens; Kevin C O'Connor; Stephen J Elledge
Journal:  J Autoimmun       Date:  2013-03-13       Impact factor: 7.094

Review 9.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.

Authors:  Michael W Graner; Xiaoli Yu; Zhe Wang; Peter Ge Kennedy; Cecily Dupree; Min Wang; Catherin Lee; Tiffany Pointon; T Dianne Langford
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-18       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.